Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Vassilopoulos

Showing results (101-110 of 169) with videos related to

Pageof 17
Sort By:
The Breast Journal|June 9, 2023
Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant SettingEfthymia Skafida, Angeliki Andrikopoulou, Evangelos Terpos, et al.
Mediterranean Journal of Rheumatology|March 19, 2020
Five-year prospective multi-center cohort study of patients with giant cell arteritis in GreeceChristina Tsalapaki, Eleni Nikitopoulou, Kyriaki A Boki, et al.
Vaccine|October 12, 2021
A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United StatesGeorge Lazaros, Cleo Anastassopoulou, Sophia Hatziantoniou, et al.
Pathogens & Immunity|April 8, 2020
Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic TreatmentKonstantinos Thomas, Emilia Hadziyannis, Chrisoula Hatzara, et al.
Life (Basel, Switzerland)|March 28, 2024
Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent PericarditisEmilia Lazarou, Christos Koutsianas, Panagiotis Theofilis, et al.
Arthritis and Rheumatism|April 11, 2003
Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunctionDimitrios Vassilopoulos, John L Niles, Alexandra Villa-Forte, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 9, 2006
Changes in LORETA and conventional patterns of P600 after steroid treatment in multiple sclerosis patientsCharalabos C Papageorgiou, Costas Sfagos, Katerina K Kosma, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|April 24, 2018
Predictors of switching from nonsteroidal anti-inflammatory drugs to corticosteroids in patients with acute pericarditis and impact on clinical outcomeGeorge Lazaros, Alexios S Antonopoulos, Charalambos Vlachopoulos, et al.
Rheumatology (Oxford, England)|May 12, 2023
Health-related quality of life in patients with ANCA vasculitides compared to rheumatoid arthritis: a cross-sectional comparative studyAlexandros Panagiotopoulos, Konstantinos Thomas, Evangelia Argyriou, et al.
Rheumatology International|October 7, 2024
Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020-2023 versus 2016-2019 in a Nation-Wide Cohort StudyVasiliki-Kalliopi Bournia, George E Fragoulis, Panagiota Mitrou, et al.
Pageof 17

Showing results (101-110 of 169) with videos related to

Sort By:
Pageof 17
The Breast Journal|June 9, 2023
Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant SettingEfthymia Skafida, Angeliki Andrikopoulou, Evangelos Terpos, et al.
Mediterranean Journal of Rheumatology|March 19, 2020
Five-year prospective multi-center cohort study of patients with giant cell arteritis in GreeceChristina Tsalapaki, Eleni Nikitopoulou, Kyriaki A Boki, et al.
Vaccine|October 12, 2021
A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United StatesGeorge Lazaros, Cleo Anastassopoulou, Sophia Hatziantoniou, et al.
Pathogens & Immunity|April 8, 2020
Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic TreatmentKonstantinos Thomas, Emilia Hadziyannis, Chrisoula Hatzara, et al.
Life (Basel, Switzerland)|March 28, 2024
Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent PericarditisEmilia Lazarou, Christos Koutsianas, Panagiotis Theofilis, et al.
Arthritis and Rheumatism|April 11, 2003
Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunctionDimitrios Vassilopoulos, John L Niles, Alexandra Villa-Forte, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 9, 2006
Changes in LORETA and conventional patterns of P600 after steroid treatment in multiple sclerosis patientsCharalabos C Papageorgiou, Costas Sfagos, Katerina K Kosma, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|April 24, 2018
Predictors of switching from nonsteroidal anti-inflammatory drugs to corticosteroids in patients with acute pericarditis and impact on clinical outcomeGeorge Lazaros, Alexios S Antonopoulos, Charalambos Vlachopoulos, et al.
Rheumatology (Oxford, England)|May 12, 2023
Health-related quality of life in patients with ANCA vasculitides compared to rheumatoid arthritis: a cross-sectional comparative studyAlexandros Panagiotopoulos, Konstantinos Thomas, Evangelia Argyriou, et al.
Rheumatology International|October 7, 2024
Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020-2023 versus 2016-2019 in a Nation-Wide Cohort StudyVasiliki-Kalliopi Bournia, George E Fragoulis, Panagiota Mitrou, et al.
Pageof 17